when is the glp 1 pill coming out FDA has approved the first version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight Drugmakers are only months into

MEDVi operates as a technology platform connecting patients with independent licensed medical providers who make all clinical decisions

To be clear: No evidence has emerged of GLP-1s causing health problems on a large scale (though some studies have linked a few fatalities to hypoglycemia that emerged after using GLP-1s or an increased risk of pancreatitis or bowel obstruction)

This peptide, which they named 'exendin-4', not only stimulated insulin secretion in the same way as GLP-1 but also had the advantage that it remained active for more than two hours after subcutaneous injection

However, we recognize that each individual is unique

The goal is not weight loss yet

The post says baseline TSH, free T4 and TPO antibodies should be established before any GLP-1 medication is started, whether branded or compounded, and that how often to recheck thyroid function during initiation is a question for the provider